Dna Medicine Institute
Publicly observedCambridge, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Cambridge | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Dna Medicine Institute | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | PUESWMALMKD4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant10 Sept 2024Publicly observed
NIH SBIR/STTR award: 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient Management
USD 50,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2024Publicly observed
NIH SBIR/STTR award: 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient Management
USD 1,007,678.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2020Publicly observed
NIH SBIR/STTR award: TABA Supplement for Hemophilia Point-of-Care Device
USD 50,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2020Publicly observed
NIH SBIR/STTR award: Hemophilia Point-of-Care Monitoring Device and App
USD 1,000,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Sept 2020Publicly observed
NIH SBIR/STTR award: Hemophilia Point-of-Care Monitoring Device and App
USD 1,000,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.